Powder: -20°C for 3 years | In solvent: -80°C for 1 year
UMB298 is a potent and selective CBP/P300 bromodomain inhibitor. UMB298 inhibits BRD4 with IC50 of 5193nM.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 118.00 | |
5 mg | In stock | $ 291.00 | |
10 mg | In stock | $ 482.00 | |
25 mg | In stock | $ 789.00 | |
50 mg | In stock | $ 1,080.00 | |
100 mg | In stock | $ 1,480.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 297.00 |
Description | UMB298 is a potent and selective CBP/P300 bromodomain inhibitor. UMB298 inhibits BRD4 with IC50 of 5193nM. |
Targets&IC50 | BRD4:5193nM |
In vitro | UMB298 inhibits MOLM13 and MM cells growth. UMB298 reduces the H3K27ac level similar to CBP30 and causes MYC depletion as a signature of CBP inhibition in acute myeloid leukemia. UMB298 down-regulates MYC expression in MOLM13 cells. |
Molecular Weight | 479.01 |
Formula | C27H31ClN4O2 |
CAS No. | 2266569-73-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 20 mg/mL(41.75 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
UMB298 2266569-73-5 Chromatin/Epigenetic Epigenetic Reader Domain inhibit MOLM13 Inhibitor bromodomain UMB-298 selective potent UMB 298 CBP30 inhibitor